The Family Firm’s Dentsply Sirona XRAY Stock Holding History

The Family Firm’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-350	Closed	-$8.73K	–	862
2024 Q2	$8.73K	Buy	+350	New	+$10K	﹤0.01%	692

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

The Family Firm's XRAY Position: Q3 2024 in Review

The Family Firm sold out of Dentsply Sirona (XRAY) in Q3 2024, closing a stake of 350 shares — an estimated $8.73K sold.

The Family Firm first reported a position in XRAY in Q2 2024 and held it in 1 quarter. The position peaked at $8.73K in Q2 2024. 385 funds tracked by Wall St. Rank hold XRAY as of Q3 2024.

The Family Firm reported no remaining Dentsply Sirona position as of Q3 2024 after selling out during the quarter.
The Family Firm sold 350 Dentsply Sirona shares in Q3 2024, an estimated $8.73K.
The Family Firm first reported a position in Dentsply Sirona in Q2 2024 and held it in 1 quarter.
The Family Firm's Dentsply Sirona position peaked at $8.73K in Q2 2024.
385 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2024.

Based on The Family Firm's 13F filing for Q3 2024, filed 17 Oct 2024.